XERS Financials
Xeris Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$8.46
Market Cap
$760.74M
P/E Ratio
-22.9
EPS
$-0.37
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$203.07M
Gross Profit
-
Operating Income
-
Net Income
$-54.84M
EPS (Diluted)
$-0.37
Balance Sheet Highlights
Total Assets
$323.06M
Total Liabilities
$352.68M
Shareholders Equity
-
Cash & Equivalents
$71.62M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-36.98M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-27.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is XERS revenue?
XERS's most recent quarterly revenue was $203.07M. Annual revenue can be calculated by summing the four most recent quarters.
Is XERS profitable?
XERS reported a loss of $54.84M in the most recent quarter. The net profit margin is -27.0%.
What is XERS market cap?
XERS has a market capitalization of $760.74M, making it a small-cap stock.
Does XERS have debt?
View XERS's balance sheet for debt information.
What is XERS cash flow?
Cash flow data is available in the full financial statements.